SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-05-001869
Filing Date
2005-04-22
Accepted
2005-04-21 20:03:27
Documents
10
Period of Report
2005-04-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_4278.htm 8-K 15606
2 EX-10.1 exhibit1.htm EX-10.1 12893
3 EX-10.2 exhibit2.htm EX-10.2 12807
4 EX-10.3 exhibit3.htm EX-10.3 12798
5 EX-10.4 exhibit4.htm EX-10.4 12808
6 EX-10.5 exhibit5.htm EX-10.5 12792
7 EX-10.6 exhibit6.htm EX-10.6 12795
8 EX-10.7 exhibit7.htm EX-10.7 12788
9 EX-10.8 exhibit8.htm EX-10.8 12797
10 EX-10.9 exhibit9.htm EX-10.9 12801
  Complete submission text file 0001299933-05-001869.txt   132407
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 05765838
SIC: 2836 Biological Products, (No Diagnostic Substances)